Formulation
- Aspire India Lifecare LLP was born in 2017 with a vision to enter the world formulation markets. It aims to serve healthcare and is well organised to implement cutting edge technologies to optimize processes and improve the innovation in healthcare.
- Aspire gets manufactured and markets a range of Critical Care products which offer superior quality and affordability to our end customers. It currently exports critical care, anesthetic, anti-emetic, antibiotic infusion and various other therapeutic products in parenteral form.
- We have invested heavily into various formulations facilities and look forward to entering into Regulated markets in the coming years. At present , Aspire has its associates in South East Asia, certain parts of Latin America , CIS and African countries apart from its presence in India in niche market segment.
- Currently, we are exporting to countries like Myanmar, Cambodia , Guyana, Nigeria , Ghana , Ivory Coast, Russia, Uzbekistan, Armenia and Georgia.
- With over 100 products under registration, Aspire further aims to enter into the Regulated Markets of Europe and GCC by 2025.
| PRODUCT NAME | |
|---|---|
| Iron Sucrose Injection | Propofol Injectable Emulsion |
| Meropenem for Injection | Levocarnitine Injection |
| Ondanseteron Injection | Citicholine Injection |
| Ceftriaxone Injection and its combinations | Levofloxacin Infusion |
| Tranexamic Acid Injection | L-Ornithine, L-Aspartate Infusion |
| Acyclovir Injection | Artesunate for Injection |
| Rabeprazole Injection | Alpha Beta Arteether Injection |
| Omeprazole Injection | Clindamycin Injection |
| Cefepime Injection and its combinations | Granisetron Injection |
Above are few of our registered products